tradingkey.logo
tradingkey.logo
Search

Artivion Inc

AORT
Add to Watchlist
23.869USD
+0.319+1.35%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.16BMarket Cap
93.02P/E TTM

Artivion Inc

23.869
+0.319+1.35%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+1.35%

5 Days

+8.35%

1 Month

+13.39%

6 Months

-47.67%

Year to Date

-47.67%

1 Year

-22.38%

Key Figures
23.640Open
24.150High
496.89KVolume
93.02P/E TTM
50.73P/E Dynamic
--Dividend TTM
1.02%Turnover Ratio
23.550Prev. Close
23.310Low
7.69MTurnover
LossP/E Static
2.57P/B
0.00%Div Yield TTM
1.40%ROA
48.25052wk High
0.70Volume Ratio
-13.34MNet Profit
48.50MShares
0.2566EPS TTM
1.29Beta
3.14%ROE
19.16052wk Low
3.57%Amplitude
64.85%Gross Margin
1.16BMarket Cap
6.92Reward/Risk
2.21%Risk Rate

TradingKey Stock Score of Artivion Inc

Currency: USD Updated: 2026-07-01

Key Insights

Artivion Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 17 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 42.00.In the medium term, the stock price is expected to trend down.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Artivion Inc's Score

Industry at a Glance

Industry Ranking
17 / 204
Overall Ranking
70 / 4564
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Artivion Inc Highlights

StrengthsRisks
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 24.67% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 91.78, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 45.29M shares, increasing 1.10% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 684.09K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.13.

Analyst Rating

Based on 8 analysts
Buy
Current Rating
42.000
Target Price
+86.92%
Upside Space

Artivion Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Artivion Inc Info

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Ticker SymbolAORT
CompanyArtivion Inc
CEOMackin (James Patrick)
Websitehttps://artivion.com/

FAQs

What is the current price of Artivion Inc (AORT)?

The current price of Artivion Inc (AORT) is 23.55.

What is the symbol of Artivion Inc?

The ticker symbol of Artivion Inc is AORT.

What is the 52-week high of Artivion Inc?

The 52-week high of Artivion Inc is 48.25.

What is the 52-week low of Artivion Inc?

The 52-week low of Artivion Inc is 19.16.

What is the market capitalization of Artivion Inc?

The market capitalization of Artivion Inc is 1.14B.

Is Artivion Inc (AORT) currently rated as Buy, Hold, or Sell?

According to analysts, Artivion Inc (AORT) has an overall rating of Buy, with a price target of 42.00.

What is the Earnings Per Share (EPS TTM) of Artivion Inc (AORT)?

The Earnings Per Share (EPS TTM) of Artivion Inc (AORT) is 0.22.